Charles N. York II
2017
In 2017, Charles N. York II earned a total compensation of $1.1M as Chief Financial Officer and Vice President at Aeglea BioTherapeutics, a 65% increase compared to previous year.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Salary | $325,000 |
| Stock Awards | $660,082 |
| Other | $15,707 |
| Total | $1,130,789 |
York received $660.1K in stock awards, accounting for 58% of the total pay in 2017.
York also received $130K in bonus, $325K in salary and $15.7K in other compensation.
Rankings
In 2017, Charles N. York II's compensation ranked 8,388th out of 14,666 executives tracked by ExecPay. In other words, York earned more than 42.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,388 out of 14,666 | 43rd |
Division Manufacturing | 3,177 out of 5,768 | 45th |
Major group Chemicals And Allied Products | 1,051 out of 2,074 | 49th |
Industry group Drugs | 828 out of 1,730 | 52nd |
Industry Pharmaceutical Preparations | 647 out of 1,329 | 51st |
Source: SEC filing on April 16, 2018.
York's colleagues
We found three more compensation records of executives who worked with Charles N. York II at Aeglea BioTherapeutics in 2017.